Unit 2: Research Trends in Microbiology & Biochemistry

Research in the life sciences advances along "thrust areas" — nationally and institutionally prioritised themes that attract funding, infrastructure and talent because they promise high scientific or translational impact. For a dissertation, identifying a thrust area anchors the problem statement in current disciplinary momentum, ensures resource availability, and improves publishability. This unit orients the student to the dominant thrust areas in microbiology and biochemistry as of the mid-2020s.

• Definition of a thrust area: a research domain designated as a priority by funding bodies (e.g., DBT, ICMR, DST, NIH, Wellcome Trust) on grounds of scientific novelty, societal need or economic value.
• Selection criteria: novelty, feasibility within available facilities, translational potential, alignment with funding calls, and availability of a supervisor's expertise.
• Cross-cutting enablers: high-throughput sequencing, mass spectrometry, CRISPR editing, bioinformatics pipelines, and AI/ML analysis now underpin nearly every thrust area in both disciplines.
• Convergence: microbiology and biochemistry increasingly overlap through molecular microbiology, systems biology and multi-omics, so many thrust areas belong jointly to both.

II. Thrust Research Areas in Microbiology

Priority domains driving current microbiological research.

A. Orientation

Microbiology's thrust areas cluster around three pressures: the antimicrobial resistance crisis, the microbiome revolution, and the demand for sustainable bioprocesses.

B. Discussion on thrust research area — Microbiology

The following are the leading thrust domains, each defined by a driving problem, a characteristic method, and a translational endpoint.

• Antimicrobial resistance (AMR): the study of mechanisms by which bacteria evade antibiotics and strategies to counter them.
  • Mechanisms studied: β-lactamase and carbapenemase enzymes, efflux pumps, target-site mutation, and horizontal gene transfer of resistance plasmids.
  • Methods: minimum inhibitory concentration (MIC) assays, whole-genome sequencing to detect resistance genes (e.g., blaNDM-1, mecA), and resistome profiling.
  • Endpoint: novel antibiotics, adjuvants, bacteriophage therapy, and AMR surveillance networks.
• Microbiome research: characterisation of microbial communities and their host interactions.
  • Targets: the human gut microbiome and its links to metabolism, immunity and neurology (the gut–brain axis); soil and rhizosphere microbiomes for agriculture.
  • Methods: 16S rRNA amplicon sequencing for taxonomy and shotgun metagenomics for functional profiling.
  • Endpoint: probiotics, faecal microbiota transplantation, and microbiome-based diagnostics.
• Environmental and industrial microbiology: harnessing microbes for sustainability.
  • Applications: bioremediation of heavy metals and hydrocarbons, biofuel production (bioethanol, biohydrogen), and microbial fuel cells.
  • Methods: enrichment culture, biofilm and bioreactor studies, and degradation-pathway elucidation.
• Virology and emerging infectious diseases: intensified after COVID-19.
  • Focus: viral genomics, variant surveillance, mRNA and viral-vector vaccine platforms, and antiviral drug discovery.
  • Methods: RT-PCR, next-generation sequencing for variant tracking, and plaque assays.
• Synthetic and molecular microbiology: engineering microbes for defined outputs.
  • Focus: engineered E. coli and yeast chassis for producing insulin, artemisinin precursors and industrial enzymes; CRISPR-based gene circuits.

III. Thrust Research Areas in Biochemistry

Priority domains driving current biochemical research.

A. Orientation

Biochemistry's thrust areas revolve around understanding molecules of life at scale (omics), targeting metabolism in disease, and engineering biomolecules for therapy and industry.

B. Discussion on thrust research area — Biochemistry

Each domain below is defined by the biomolecule class it interrogates and the analytical platform that enables it.

• Structural biology and drug design: determining three-dimensional macromolecular structure to guide therapeutics.
  • Methods: X-ray crystallography, cryo-electron microscopy (cryo-EM), NMR, and AlphaFold-based structure prediction.
  • Application: structure-based and rational drug design docking small molecules to enzyme active sites.
  • Endpoint: enzyme inhibitors, e.g., protease inhibitors for HIV and SARS-CoV-2 Mpro.
• Enzyme technology and enzymology: exploiting and re-engineering catalytic proteins.
  • Focus: enzyme kinetics (Michaelis–Menten behaviour), immobilisation on supports, and directed evolution to alter substrate specificity.
  • Application: industrial biocatalysts (amylases, lipases, proteases) in detergents, food and pharma.
• Metabolomics and systems biochemistry: global measurement of metabolic state.
  • Methods: LC-MS/MS and NMR metabolite profiling integrated with genomics and proteomics.
  • Application: biomarker discovery for cancer and metabolic disease, and reconstruction of metabolic flux networks.
• Clinical and molecular biochemistry of disease: mechanistic study of pathology.
  • Focus: cancer metabolism (the Warburg effect — aerobic glycolysis), diabetes and insulin signalling, and oxidative-stress biochemistry (reactive oxygen species, antioxidant enzymes like superoxide dismutase).
  • Endpoint: diagnostic assays and metabolic-pathway-targeted drugs.
• Nutraceuticals and natural-product biochemistry: bioactive compounds from natural sources.
  • Focus: isolation and assay of polyphenols, flavonoids and antioxidants; free-radical scavenging (DPPH assay).
• Nanobiotechnology in biochemistry: interfacing biomolecules with nanoscale materials.
  • Application: enzyme-nanoparticle biosensors and targeted drug-delivery conjugates.

IV. Cross-Disciplinary and Enabling Trends

Themes shared across microbiology and biochemistry.

A. Orientation

The sharpest current growth lies where the two disciplines fuse with computation and genome engineering; dissertations increasingly sit in this overlap.

B. Omics and Systems Biology

Integrating whole-molecule datasets to build predictive models of living systems.

• The omics stack: genomics (DNA), transcriptomics (RNA), proteomics (proteins) and metabolomics (metabolites) analysed together as multi-omics.
• Systems biology: treats the cell as a network, using flux balance analysis and pathway modelling rather than single-gene study.
• Anchor example: metagenomics reads an entire community's DNA without culturing, revealing that most environmental microbes are "unculturable."

C. Genome Editing and Synthetic Biology

Precise, programmable rewriting of genetic material.

• CRISPR-Cas9: a guide RNA directs the Cas9 nuclease to a specific genomic locus for a double-strand cut and edit.
  
  TEXT

  5'-...NNNNNNNNNNNNNNNNNNNN NGG-3'   target DNA
         |||||||||||||||||||| (PAM)
  3'-...guide RNA (20 nt)...-5'       Cas9 cleaves ~3 bp upstream of PAM

  • Guide RNA: the ~20-nucleotide sequence conferring target specificity.
  • PAM: protospacer adjacent motif (NGG for S. pyogenes Cas9), required for Cas9 recognition.
• Synthetic biology: designs standardised genetic parts (promoters, ribosome binding sites, coding sequences) to build novel circuits and metabolic pathways.

D. Bioinformatics and AI/ML

Computation as the fourth pillar of experimental design and analysis.

• Role: sequence alignment (BLAST), phylogenetics, structure prediction (AlphaFold), and machine-learning classification of omics data.
• Impact: shifts research from hypothesis-then-experiment toward data-driven discovery; essential for handling terabyte-scale sequencing output.

V. Selecting a Thrust Area for a Dissertation

Translating trends into a viable research problem.

A. Orientation

A thrust area is a starting point, not a project; the student must narrow it to a specific, answerable question that fits local constraints.

B. Criteria for Selection

Matching an area to feasibility is what makes a dissertation completable.

• Relevance: aligns with a current funding call or a recognised societal problem (e.g., AMR surveillance).
• Feasibility: the required instruments (sequencer, HPLC, spectrophotometer) and reagents are accessible within the institution and budget.
• Supervisory expertise: a guide with a track record in the domain de-risks methodology.
• Novelty gap: a literature review must confirm the specific question is unanswered, not merely the broad area unexplored.
• Time and scope: achievable within the dissertation timeline, avoiding open-ended discovery projects.

C. From Thrust Area to Research Question

Narrowing proceeds from broad domain to testable hypothesis.

• Funnel logic: thrust area → specific problem → literature gap → objectives → hypothesis.
  • Example progression: AMR (thrust) → carbapenem resistance in hospital Klebsiella (problem) → limited local blaNDM prevalence data (gap) → "determine prevalence and genotype of carbapenemase genes in clinical isolates" (objective).
• Objectives: framed as SMART statements — specific, measurable, achievable, relevant, time-bound.

D. Significance and Limitations of the Thrust-Area Approach

The approach directs effort efficiently but carries risks the researcher must manage.

1. Significance: concentrates funding and infrastructure, enables collaboration and comparison across groups, and raises translational and publication potential by tackling recognised problems.
2. Limitations: high competition and risk of duplication in crowded areas; funding-driven priorities may sideline fundamental or "unfashionable" questions; rapid trend shifts can render a long project less current by completion.